Evidence map›Paper›PMID 28740747›Full record

ArticlePeerJ2017

Aisha I El Habbash, Najihah Mohd Hashim, Mohamed Yousif Ibrahim, Maizatulakmal Yahayu, Fatima Abd Elmutaal Omer, Mashitoh Abd Rahman, Noraziah Nordin, Gwendoline Ee Cheng Lian

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in PeerJ, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.5field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Frontiers in pharmacology · 2025
    Article
  2. Article
  3. Article
  4. Natural Products Targeting the Mitochondria in Cancers.Molecules (Basel, Switzerland) · 2020
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Aisha I El HabbashPharmacy Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Najihah Mohd HashimPharmacy Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Mohamed Yousif IbrahimPharmacy Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Maizatulakmal YahayuDepartment of Bioproduct Research & Innovation, Institute of Bioproduct Development (IBD), Universiti Teknologi Malaysia, Johor Bahru, Malaysia.
Fatima Abd Elmutaal OmerPharmacy Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Mashitoh Abd RahmanPharmacy Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Noraziah NordinPharmacy Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Gwendoline Ee Cheng LianDepartment of Chemistry, Faculty of Science, Universiti Putra Malaysia, Selangor, Malaysia.
University of Malaya · MYUniversiti Putra Malaysia · MYUniversiti Sains Islam Malaysia · MYUniversity of Technology Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natural medicinal products possess diverse chemical structures and have been an essential source for drug discovery. Therefore, in this study, α-mangostin (AM) is a plant-derived compound was investigated for the apoptotic effect on human cervical cancer cells (HeLa). The cytotoxic effects of AM on the viability of HeLa and human normal ovarian cell line (SV40) were evaluated by using MTT assay. Results showed that AM inhibited HeLa cells viability at concentration- and time-dependent manner with IC

Indexed as

AntitumorApoptosisHeLaα-mangostin

Identifiers

PMID28740747
PMCPMC5522721
OpenAlexW2738220275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.